APVO vs MSFT: Which Stock is Better?
Side-by-side comparison of Aptevo Therapeutics Inc and Microsoft Corp in 2026
APVO
Aptevo Therapeutics Inc
$4.42
MSFT
Microsoft Corp
$395.00
Key Metrics Comparison
| Metric | APVO | MSFT | Winner |
|---|---|---|---|
| Market Cap | $6.90M | N/A | APVO |
| P/E Ratio | 0.00 | 36.30 | APVO |
| EPS (TTM) | $7758.20 | $13.70 | APVO |
| Revenue Growth | -1.0% | 14.9% | MSFT |
| Gross Margin | 0.0% | 68.8% | MSFT |
Analyze APVO
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is APVO or MSFT a better investment?
Comparing APVO and MSFT: Aptevo Therapeutics Inc has a market cap of $6.90M while Microsoft Corp has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between APVO and MSFT?
APVO (Aptevo Therapeutics Inc) and MSFT (Microsoft Corp) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: APVO or MSFT?
Based on P/E ratios, APVO trades at a lower multiple (0.0x vs 36.3x).
Which is growing faster: APVO or MSFT?
MSFT has higher revenue growth at 14.9% vs -1.0% for APVO.
Which company is more profitable: APVO or MSFT?
Microsoft Corp (MSFT) has higher gross margins at 68.8% compared to 0.0% for APVO.
Which is the larger company: APVO or MSFT?
Aptevo Therapeutics Inc (APVO) is larger with a market cap of $6.90M compared to N/A for MSFT.
Should I buy APVO or MSFT in 2026?
Both APVO and MSFT have investment merit. APVO trades at $4.42 while MSFT trades at $395.00. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between APVO and MSFT stock?
Key differences: Market Cap ($6.90M vs N/A), P/E Ratio (0.0x vs 36.3x), Revenue Growth (-1.0% vs 14.9%), Gross Margin (0.0% vs 68.8%).